09/04/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
6:27 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:30 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:30 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:31 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/11/2024
3:31 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:32 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:38 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
7:11 PM | Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
7:12 PM | Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:28 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
4:20 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
5:46 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
5:14 PM | Axsome Therapeutics (Subject)
Jacobson Mark L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
7:27 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:02 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
6:06 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
7:05 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
6:09 PM | Axsome Therapeutics (Subject)
JEFFS ROGER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:25 PM | Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:34 PM | Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:34 PM | Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:34 PM | Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:18 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:20 PM | Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:39 PM | Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
7:10 AM | Axsome Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2024
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
2:46 PM | Axsome Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:26 AM | Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
01/08/2024
6:10 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:11 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:39 PM | Axsome Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:05 AM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
7:30 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/12/2023
7:33 PM | Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2023
4:03 PM | Axsome Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Perfect Crypto Buying Opportunity for 50 Cents (Ad) When cryptos take a hit, the mom and pop investors run for the hills.
But the top investors keep buying with both fists. They know it's only a matter of time before another bull run.
Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank Go here to get full details on this crypto now. |
09/15/2023
5:30 PM | Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:32 PM | Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
